Global Markets

Additional European Equity News - 16th November 2026

ORIGINAL · NewsquawkAdditional European Equity News - 16th November 2026Read originalHide original

AstraZeneca (AZN LN) - Co. announces that its Klygefa has been approved in the EU as an add-on to standard therapy for the treatment of generalised myasthenia gravis in adults who are AChR antibody positive. To add, its Baxfendy has been recommended for approval in the EU for the treatment of adults with arterial hypertension insufficiently controlled with at least two antihypertensive medicinal products. (AstraZeneca) Bunzl (BNZL LN) - Co. announces the start of the second tranche of its GBP 500mln share buyback programme. (Bunzl) Coca-Cola HBC (CCH LN) - Co. gets approval for a secondary listing on the JSE, with the exchange granting approval for a fast-track inward secondary listing. (Coca-Cola HBC) Legal & General (LGEN LN) - Q3 Trading Update: PRT written or exclusive GBP 6.7bln, Solvency 2 ratio at 213% as of 30th September. Co. is on track to meet or exceed strategic targets and is to exceed GBP 400mln of asset optimisation in 2026. Sees 2027 core operating EPS growth above the top end of its 6-9% target range. (Legal & General) Nokia (NOKIA FH), Telia (TELIA SS) - Nokia forms an AI Gigafactory Northern consortium alongside Nscale, Skeleton, Telia and Verda to develop a federated, multi-site AI infrastructure network across the Nordic and Baltic region. The partners plan to submit a bid under the European High-Performance Computing Joint Undertaking's AI Gigafactory tender, combining AI computing capacity, sovereign cloud services, high-speed connectivity and decarbonised energy. (Nokia) Philips (PHIA NA) - Co. is to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 AGM. (Philips) Bellway (BWY LN) downgraded to Hold from Buy at Jefferies Clariant (CLN SW) downgraded to Equal Weight from Overweight at Barclays Prosus (PRX NA) reinitiated with Buy at Citi Solvay (SOLB BB) upgraded to Equal Weight from Underweight at Barclays Wacker Chemie (WCH GY) upgraded to Overweight from Equal Weight at Barclays Ypsomed (YPSN SW) downgraded to Neutral from Buy at Citi

StockNow breaking-news AI analysis

Legal & General reported £6.7 billion of PRT written or exclusive business and expects 2027 core operating EPS growth above its 6–9% target range.

News detail

AstraZeneca (AZN LN) - Co. announces that its Klygefa has been approved in the EU as an add-on to standard therapy for the treatment of generalised myasthenia gravis in adults who are AChR antibody positive. To add, its Baxfendy has been recommended for approval in the EU for the treatment of adults with arterial hypertension insufficiently controlled with at least two antihypertensive medicinal products. (AstraZeneca) Bunzl (BNZL LN) - Co. announces the start of the second tranche of its GBP 500mln share buyback programme. (Bunzl) Coca-Cola HBC (CCH LN) - Co. gets approval for a secondary listing on the JSE, with the exchange granting approval for a fast-track inward secondary listing. (Coca-Cola HBC) Legal & General (LGEN LN) - Q3 Trading Update: PRT written or exclusive GBP 6.7bln, Solvency 2 ratio at 213% as of 30th September. Co. is on track to meet or exceed strategic targets and is to exceed GBP 400mln of asset optimisation in 2026. Sees 2027 core operating EPS growth above the top end of its 6-9% target range. (Legal & General) Nokia (NOKIA FH), Telia (TELIA SS) - Nokia forms an AI Gigafactory Northern consortium alongside Nscale, Skeleton, Telia and Verda to develop a federated, multi-site AI infrastructure network across the Nordic and Baltic region. The partners plan to submit a bid under the European High-Performance Computing Joint Undertaking's AI Gigafactory tender, combining AI computing capacity, sovereign cloud services, high-speed connectivity and decarbonised energy. (Nokia) Philips (PHIA NA) - Co. is to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 AGM. (Philips) Bellway (BWY LN) downgraded to Hold from Buy at Jefferies Clariant (CLN SW) downgraded to Equal Weight from Overweight at Barclays Prosus (PRX NA) reinitiated with Buy at Citi Solvay (SOLB BB) upgraded to Equal Weight from Underweight at Barclays Wacker Chemie (WCH GY) upgraded to Overweight from Equal Weight at Barclays Ypsomed (YPSN SW) downgraded to Neutral from Buy at Citi

3 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more